Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

CUSIP: 84833T103

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 7 signals
Share change
-1,092,122
Put/Call ratio
1184%
SEC-reported price per share
$2.00
Number of holders
61
Value change
+$134,944
Number of buys
23
Open additional details 1 more signal available
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
55,705,828

Security key

84833T103

Report period

Q3 2022

Institutions

61

Top holders

10

Ownership snapshot

Top reported holders of SPRO - Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Aquilo Capital Management...
Disclosed value leader
Aquilo Capital Management...
Comparable rows
15/15
Latest evidence
22 Sep 2022
3/4/5 13F Lead comparable stake: 9.6% Showing 1-6 of 15 holder rows.

Quick read

Aquilo Capital Management, LLC leads the comparable SEC ownership view at 9.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Aquilo Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Aquilo Capital Management, LLC 9.6%
BVF INC/IL 5.5%
Atlas Venture Associates IX, LLC 2.5%
VANGUARD GROUP INC 2.2%
Atlas Venture Life Science Adviso... 1.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Aquilo Capital Management, LLC
3/4/5 13F
10%+ Owner · Company
9.6%
from 13F
$4,342,682
3,419,435 shares
22 Sep 2022
BVF INC/IL
13F
Company
13F
5.5%
$2,289,000
3,089,615 shares
30 Jun 2022
Atlas Venture Associates IX, LLC
13F
Company
13F
2.5%
$1,019,000
1,376,968 shares
30 Jun 2022
VANGUARD GROUP INC
13F
Company
13F
2.2%
$924,000
1,245,992 shares
30 Jun 2022
Atlas Venture Life Science Advisors, LLC
13F
Company
13F
1.9%
$764,000
1,031,160 shares
30 Jun 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
1.7%
$696,000
939,017 shares
30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
61
Shares
19,852,133
Rows available
61
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
60
Q3 2022 holders
61
Holder diff
1
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .